Lipophilicity optimization strategy balances membrane permeability against aqueous solubility guiding formulation development. Log P measurement quantitates lipophilicity. Excessive lipophilicity impairs solubility causing bioavailability loss. Insufficient lipophilicity prevents membrane penetration. Structure modification iteratively optimises lipophilicity.
Formulation excipients enhance apparent solubility. Supersaturation strategies exploit kinetic solubility. Regulatory submissions justify lipophilicity selections. Post-approval monitoring confirms bioavailability maintenance. Emerging structure-activity relationship analysis guides optimisation.
General Biopharmaceutical Concepts
Lipophilicity Optimization Strategy
Lipophilicity optimisation adjusts the hydrophobic properties of drug candidates to improve absorption, distribution, efficacy and pharmacokinetic performance.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →